Julian Lin's Highest Conviction Idea (Ever)? Cannabis. (Podcast)

Summary

  • Julian Lin has a new cannabis focused marketplace service, Cannabis Growth Portfolio.
  • We discuss his thoughts on EBITDA, ETFs using total return swaps to own US MSOs, rebalancing away from Canadian operators.
  • Uplisting is the clearest catalyst for cannabis stocks. Tilray coming for the US.
  • Legalization is not the thesis to owning cannabis stocks. California concerns.

Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts, Google Podcasts, Spotify, and Stitcher.

Julian Lin, who originally appeared on our MasterClass episodes, has a new cannabis focused marketplace service, Cannabis Growth Portfolio. Cannabis is his highest conviction idea and largest position in terms of sector weight. We're seeing growing investor impatience as companies are reporting high growth numbers, especially in recent earnings reports - if they were in a major exchange and a normal growth stock, they would go up 30% in a day, but given the sector and lack of serious coverage, some of these stocks are actually going down. Legalization is not the thesis to be owning cannabis stocks. SAFE Banking, though it looks far off and is getting hard to keep up with, may lead to improved interest expense. Thoughts on EBITDA. California concerns and whether The Parent Company (OTCQX:GRAMF) and Glass House (OTC:GLASF) belong in a portfolio.

Editor's Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.

This article was written by

On The Cannabis Investing Podcast, host Rena Sherbill provides actionable investment insight and the context with which to understand the burgeoning cannabis industry. Interviews with C-level executives, analysts and sector experts give you investment ideas to consider, help you think through your investing approach and give you a new lens with which to understand this ever-growing sector.

Recommended For You

Comments (31)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.